Newsbenzinga
Boston Scientific Lowers FY2026 Adj EPS Guidance from $3.28-$3.32 to $3.16-$3.18 vs $3.23 Est; Lowers FY2026 Sales Guidance from $21.178B-$21.379B to $20.927B vs $21.143B Est
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…